In vitro methods for assessing anti-inflammatory drug activity (Abstract)

1977 ◽  
pp. 387-389
Author(s):  
A. Tursi ◽  
M. P. Loria ◽  
G. Specchia ◽  
L. Bonomo
2021 ◽  
pp. 120516
Author(s):  
Renan Barrach Guerra ◽  
Diogo Alves Gálico ◽  
Thais Fernanda de Campos Fraga-Silva ◽  
Julia Aguiar ◽  
James Venturini ◽  
...  

2019 ◽  
Vol 29 (12) ◽  
pp. 1487-1491 ◽  
Author(s):  
Brandon D. Eden ◽  
Andrew J. Rice ◽  
Troy D. Lovett ◽  
Olivia M. Toner ◽  
Evan P. Geissler ◽  
...  

2016 ◽  
Vol 36 ◽  
pp. 55-61 ◽  
Author(s):  
Alok Mahor ◽  
Sunil Kumar Prajapati ◽  
Amita Verma ◽  
Rishikesh Gupta ◽  
Thakur Raghu Raj Singh ◽  
...  

Author(s):  
Jayakumari S ◽  
Jijith Us

Context: The development of in vitro methods is important in drug discovery process due to the restriction of animal use in the pharmacological screening process.Objective: The objective of the review was to understand the in vitro pharmacological screening methods for anti-inflammatory agents.Methods: The present review details various in vitro methods available for the screening of activity of therapeutic agents against inflammation.Results: Inhibition and measurement of nitric oxide production, mast cell degranulation, leukocyte adhesion assay, platelet-neutrophil adhesion assay, lipopolysaccharide-induced response assay, N-formyl-methionyl-leucyl-phenylalanine-induced O2 generation by polymorphonuclear cells, and cyclooxygenase assays are discussed in this review.Conclusions: These methods help to understand the real mechanism of inflammation and mediators involved in this process and help toidentify new compounds possessing the anti-inflammatory activity.


1979 ◽  
Vol 7 (5) ◽  
pp. 351-353 ◽  
Author(s):  
G Passiu ◽  
M G Piras ◽  
G Perpignano ◽  
G Ibba ◽  
U Carcassi

In thirty-two patients, divided into four groups: normal, G-6-PD deficient, β-thalaxemic heterozygote and carriers of both anomalies, the variations in erythrocyte GSH were studied after incubation with APH and a nonsteroidal anti-inflammatory drug: tolmetin sodium. The results obtained show a considerable fall in GSH after incubation with APH above all in the G-6-PD deficient patients and in the carriers of both anomalies. On the other hand, after incubation with the drug under examination there were no significant variations in the erythrocyte GSH.


Sign in / Sign up

Export Citation Format

Share Document